Tibia fracture in rats results in chronic vascular and nociceptive changes in the injured limb resembling complex regional pain syndrome (CRPS) and up-regulates expression of interleukin 1b (IL-1b), interleukin IL-6 (IL-6), tumor necrosis factor-a (TNF-a), and nerve growth factor-b (NGF-b) in the hindpaw skin. When fractured rats are treated with cytokine or NGF inhibitors nociceptive sensitization is blocked. Because there is no leukocyte infiltration in the hindpaw skin we postulated that resident skin cells produce the inflammatory mediators causing nociceptive sensitization after fracture. To test this hypothesis rats underwent distal tibia fracture and hindlimb casting for 4 weeks, then the hindpaw skin was harvested and immunostained for keratin, cytokines and NGF. BrdU staining was used to evaluate cell proliferation. Hindpaw nociceptive thresholds, edema, and temperature were tested before and up to 96 h after intraplantar injections of IL-6 and TNF-a. Tibia fracture caused keratinocyte activation, proliferation, and up-regulated IL-1b, IL-6, TNF-a and NGF-b protein expression in the hindpaw keratinocytes. Local injections of IL-6 and TNF-a induced hindpaw mechanical allodynia lasting for several days and modest increases in temperature and edema. These data indicate that activated keratinocytes proliferate and express IL-1b, IL-6, TNF-a, and NGF-b after fracture and that excess amounts of inflammatory mediators in the skin cause sustained nociceptive sensitization. This is the first study demonstrating in vivo keratinocyte expression of IL-6, TNF-a and NGF-b in a CRPS model and we postulate that the keratinocyte is the primary cellular source for the inflammatory signals mediating cutaneous nociceptive sensitization in early CRPS.
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Introduction
Complex regional pain syndrome (CRPS) is a painful, disabling and often chronic condition affecting the extremities and is a frequent sequelae of distal tibia [45] and radius fractures [4]. Recently we described a distal tibia fracture model in rats that exhibits chronic unilateral hindlimb warmth, edema, facilitated spontaneous protein extravasation, allodynia, unweighting, and periarticular osteoporosis [18] . This constellation of post-fracture changes closely resembles the clinical presentation of patients with acute CRPS.
The inflamed appearance of the affected CRPS limb has led to the hypothesis that the local production of inflammatory mediators might be involved in the etiology of the condition. In support of this idea, treating fractured rats with the global cytokine inhibitor pentoxifylline, a TNF inhibitor (etanercept), an IL-1 receptor antagonist (anakinra) or an anti-NGF antibody (tanezumab) blocked the development of hindpaw allodynia and unweighting at 4 weeks post-fracture [31, 42, 43, 55] . All these drugs (except pentoxifylline) are large molecular weight proteins that cannot cross the blood brain barrier, suggesting a peripheral site of action. These treatments also inhibited the increase in spinal cord Fos expression characterizing this and other rodent models of painful conditions [42, 43] . In addition, at 4 weeks after fracture there was a dramatic increase in hindpaw skin expression IL-1b, IL-6, TNF-a, and NGF-b, measured at both the mRNA and protein levels [42, 43, 55] . IL-6 and TNF-a levels are elevated in suction blister fluid obtained from the skin of the affected limb, when compared to the contralateral side, in CRPS patients [21, 22] . Although cutaneous inflammatory mediator expression appears up-regulated in the CRPS limb, there is no evidence of classical immune system activation in these patients [9, 26, 41] . Similarly, no leukocyte infiltration is observed in the hind- 
